GIM
SGMO

Granahan Investment Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Granahan Investment Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-348,473
Closed -$3.14M – 194
2021
Q3 		$3.14M Buy
348,473
+117,129
+51% +$1.16M 0.06% 174
2021
Q2 		$2.77M Buy
231,344
+12,876
+6% +$146K 0.05% 174
2021
Q1 		$2.74M Sell
218,468
-39,508
-15% -$532K 0.06% 163
2020
Q4 		$4.03M Buy
257,976
+144,588
+128% +$1.69M 0.09% 144
2020
Q3 		$1.07M Sell
113,388
-10,563
-9% -$114K 0.04% 169
2020
Q2 		$1.11M Buy
123,951
+22,853
+23% +$212K 0.04% 167
2020
Q1 		$644K Sell
101,098
-1,537
-1% -$11.4K 0.03% 170
2019
Q4 		$859K Buy
102,635
+1,016
+1% +$9.34K 0.04% 162
2019
Q3 		$920K Buy
101,619
+7,370
+8% +$82.7K 0.05% 158
2019
Q2 		$1.01M Sell
94,249
-2,652
-3% -$28.2K 0.05% 162
2019
Q1 		$924K Sell
96,901
-7,116
-7% -$72.7K 0.05% 173
2018
Q4 		$1.19M Sell
104,017
-39,250
-27% -$488K 0.08% 158
2018
Q3 		$2.43M Buy
143,267
+1,919
+1% +$29.2K 0.13% 139
2018
Q2 		$2.01M Buy
141,348
+11,993
+9% +$199K 0.12% 164
2018
Q1 		$2.46M Sell
129,355
-26,349
-17% -$563K 0.18% 139
2017
Q4 		$2.55M Sell
155,704
-309,386
-67% -$4.6M 0.2% 131
2017
Q3 		$6.98M Sell
465,090
-241,769
-34% -$2.67M 0.58% 65
2017
Q2 		$6.22M Sell
706,859
-326,000
-32% -$2.09M 0.57% 64
2017
Q1 		$5.37M Buy
1,032,859
+794,508
+333% +$3.19M 0.54% 68
2016
Q4 		$727K Buy
+238,351
New +$868K 0.03% 181
2015
Q2 		– Sell
-95,400
Closed -$1.5M – 240
2015
Q1 		$1.5M Buy
+95,400
New +$1.48M 0.04% 219

Other funds holding SGMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Granahan Investment Management's SGMO Position: Q4 2021 in Review

Granahan Investment Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2021, closing a stake of 348,473 shares — an estimated $3.14M sold.

Granahan Investment Management first reported a position in SGMO in Q1 2015 and held it in 21 quarters. The position peaked at $6.98M in Q3 2017. 193 funds tracked by Wall St. Rank hold SGMO as of Q4 2021.

  • Granahan Investment Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2021 after selling out during the quarter.
  • Granahan Investment Management sold 348,473 SANGAMO THERAPEUTICS INC shares in Q4 2021, an estimated $3.14M.
  • Granahan Investment Management first reported a position in SANGAMO THERAPEUTICS INC in Q1 2015 and held it in 21 quarters.
  • Granahan Investment Management's SANGAMO THERAPEUTICS INC position peaked at $6.98M in Q3 2017.
  • 193 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2021.

Based on Granahan Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.